Anzeige
Mehr »
Login
Montag, 13.07.2020 Börsentäglich über 12.000 News von 632 internationalen Medien
News des Tages Löst FDA-Zulassung jetzt Kaufrausch aus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YD8Q ISIN: US58933Y1055 Ticker-Symbol: 6MK 
Tradegate
13.07.20
19:52 Uhr
69,00 Euro
+1,00
+1,47 %
1-Jahres-Chart
MERCK & CO INC Chart 1 Jahr
5-Tage-Chart
MERCK & CO INC 5-Tage-Chart
RealtimeGeldBriefZeit
68,8069,0020:14
68,8069,0020:12

Aktuelle News zur MERCK & CO Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16:42Merck, Dewpoint unite to find HIV cure in deal worth up to $305M3
FrMerck expands partnership with Zymeworks for multispecific antibodies8
MERCK & CO Aktie jetzt für 0€ handeln
DoBRIEF-Merck Animal Health Receives U.S. FDA Approval Of Bravecto Monthly Chews2
DoMerck expands scope of Zymeworks antibody alliance, adding close to $900M in milestones3
DoMerck: Amazing Oncology Division, Underwhelming Dividend Opportunity6
DoBRIEF-FDA Grants Priority Review To Merck's Supplemental Biologics License Application For Keytruda (Pembrolizumab) For Second-Line Treatment Of Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma4
DoMerck's Keytruda Combo Gets CRL for First-Line Liver Cancer3
DoMerck nabs accelerated review in U.S. for Keytruda for second-line cHL2
DoAstraZeneca, Merck secure EU nod for Lynparza to treat germline BRCA-mutated metastatic pancreatic cancer6
DoEisai and Merck Receive Complete Response Letter for LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma258TOKYO, July 9, 2020 - (JCN Newswire) - Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) announced today that the U.S. Food and Drug...
► Artikel lesen
DoMerck CEO Says Dearth of Black Executives Shows Lack of Progress5
DoBRIEF-Merck & Co Says Deborah H. Telman Appointed As General Counsel For Organon & Co.2
MiBRIEF-Zymeworks & Merck Sign New License Agreement3
MiMerck inks new deal with Zymeworks for up to three antibodies3
MiFoghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck2
MiMerck, Eisai's Keytruda-Lenvima combo stonewalled in liver cancer after Roche's first-in-class green light24
MiMerck Inks $425M Oncology Deal with Foghorn Therapeutics3
MiMerck Is Now Pursuing Two Coronavirus Vaccines - Is Merck Stock A Buy?8
MiFDA bars the door - for now - against Merck's star cancer drug after Roche beat them to the punch19
MiMerck teams up with cancer startup Foghorn in $425M deal5
Seite:  Weiter >>
630 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
48,4,22